Javascript must be enabled to continue!
The Radioprotective 105/MD-1 Complex Contributes to Diet-induced Obesity and Adipose Tissue Inflammation (172.23)
View through CrossRef
Abstract
Accumulating evidence suggest that innate immunity is associated with obesity-induced chronic inflammation and metabolic disorders. For example, the TLR4/MD-2 complex recognizes free fatty acids (FAAs) derived from adipose tissue and promotes adipose tissue inflammation and insulin resistance. The RP105/MD-1 complex is a homolog of the TLR4/MD-2 complex. However, the roles of RP105/MD-1 complex in adipose tissue inflammation have remained elusive. We now report that the RP105/MD-1 complex contributes to high-fat diet (HFD)-induced obesity, adipose tissue inflammation, and insulin resistance independent of TLR4 signaling. RP105 mRNA expression is dramatically increased by HFD in stromal vascular fraction of epididymal white adipose tissue (eWAT) in wild-type (WT) mice. In human, RP105 mRNA expression is also increased in the visceral adipose tissue of obese subjects. The RP105/MD-1 complex is expressed by most adipose tissue macrophages (ATMs). HFD increases RP105/MD-1 expression on the M1 ATMs in eWAT. Increased RP105 and MD-1 mRNA expression in macrophages is induced by co-culture with 3T3L-1 adipocytes. RP105 KO and MD-1 KO mice have less HFD-induced adipose tissue inflammation, hepatic steatosis and insulin resistance compared to these in WT and TLR4 KO mice. Finally, the saturated FAAs palmitic and stearic acids activate TLR4/MD-2 but not RP105/MD-1. Thus, the RP105/MD-1 complex is a major mediator of adipose tissue inflammation independent of TLR4 signaling.
Oxford University Press (OUP)
Title: The Radioprotective 105/MD-1 Complex Contributes to Diet-induced Obesity and Adipose Tissue Inflammation (172.23)
Description:
Abstract
Accumulating evidence suggest that innate immunity is associated with obesity-induced chronic inflammation and metabolic disorders.
For example, the TLR4/MD-2 complex recognizes free fatty acids (FAAs) derived from adipose tissue and promotes adipose tissue inflammation and insulin resistance.
The RP105/MD-1 complex is a homolog of the TLR4/MD-2 complex.
However, the roles of RP105/MD-1 complex in adipose tissue inflammation have remained elusive.
We now report that the RP105/MD-1 complex contributes to high-fat diet (HFD)-induced obesity, adipose tissue inflammation, and insulin resistance independent of TLR4 signaling.
RP105 mRNA expression is dramatically increased by HFD in stromal vascular fraction of epididymal white adipose tissue (eWAT) in wild-type (WT) mice.
In human, RP105 mRNA expression is also increased in the visceral adipose tissue of obese subjects.
The RP105/MD-1 complex is expressed by most adipose tissue macrophages (ATMs).
HFD increases RP105/MD-1 expression on the M1 ATMs in eWAT.
Increased RP105 and MD-1 mRNA expression in macrophages is induced by co-culture with 3T3L-1 adipocytes.
RP105 KO and MD-1 KO mice have less HFD-induced adipose tissue inflammation, hepatic steatosis and insulin resistance compared to these in WT and TLR4 KO mice.
Finally, the saturated FAAs palmitic and stearic acids activate TLR4/MD-2 but not RP105/MD-1.
Thus, the RP105/MD-1 complex is a major mediator of adipose tissue inflammation independent of TLR4 signaling.
Related Results
Exploring the Role of Visceral Fat as a Negative Regulator of Vascular Function In Obesity
Exploring the Role of Visceral Fat as a Negative Regulator of Vascular Function In Obesity
Background and Objective. Obesity promotes endothelial dysfunction, a major contributor to the development of cardiovascular disease. Work from our lab and others previously showed...
Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract
Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
iRhom2 serves as a facilitator in obesity by enhancing adipose inflammation and insulin resistance
iRhom2 serves as a facilitator in obesity by enhancing adipose inflammation and insulin resistance
Abstract
Chronic inflammation of adipose tissues contributes to obesity-triggered insulin resistance. Unfortunately, the potential molecular mech...
Radioprotectors: Nature’s Boon
Radioprotectors: Nature’s Boon
Objective:
To reduce the chances of toxicity, reduction in radiation dose or reducing the frequency of the therapy is done
which usually leads to a therapeutically poor outcome. Th...
Obstacles and Impediments of Overweight and Obesity
Obstacles and Impediments of Overweight and Obesity
Obesity is now pandemic, affecting millions of people in worldwide [1]. Obesity is defined as the excessive fat accumulation which may damage the health. Two groups of beneficial b...
Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?
Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?
The worldwide obesity epidemic has become a major health concern, because it contributes to higher mortality due to an increased risk for noncommunicable diseases including cardiov...
Novel roles of iRhom2 in the regulation of adiposity and inflammation in diet-induced obesity
Novel roles of iRhom2 in the regulation of adiposity and inflammation in diet-induced obesity
Obesity is defined by the excess accumulation of body fat. It is an increasingly common affliction of humans, affecting roughly two billion people worldwide. Chronic low-grade infl...
Obesity-Induced Increase in Cystatin C Alleviates Tissue Inflammation
Obesity-Induced Increase in Cystatin C Alleviates Tissue Inflammation
We recently demonstrated that removal of one kidney (uninephrectomy;
UniNx) in mice reduced high fat-diet (HFD)-induced adipose tissue inflammation
thereby improving adipose tissue...

